HARVARD BIOSCIENCE INC — Director's Dealing 2012

Jun 4, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2012-06-04

Reporting Person: McNaughton Thomas (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-01	Common Stock	A	41273	—	Acquired	127083	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-01	Stock option (right to buy)	$3.57	A	79037	Acquired	2022-06-01	Common Stock, par value $0.01 per share (79037)	Direct

Footnotes

F1: Includes (a) a deferred stock award of 33,400 restricted stock units which vest in equal installments on Jan 1, 2013 and Jan 1, 2014; (b) a deferred stock award of 18,750 restricted stock units which vest in equal installments on Jan 1, 2013, Jan 1, 2014 and Jan 1, 2015; (c) a deferred stock award of 41,273 restricted stock units which vest in equal installments on Jan 1, 2013, Jan 1, 2014, Jan 1, 2015 and Jan 1, 2016; and (d) 33,660 shares of common stock held by Mr. McNaughton.

F2: The options vest in four equal installments on the first four anniversaries on January 1, 2012.